Dr. Mary-Kate Lawlor presented new data #ASTRO26 showing in 81 patients with stage III uterine serous carcinoma, #EBRT significantly improved pelvic control + OS vs vaginal brachytherapy alone (4-year OS 87% vs. 55%) without increased toxicity.
@astro-org.bsky.social @oncoalert.bsky.social